SCYNEXIS, Inc. (SCYX)
5.15
-0.15
(-2.83%)
USD |
NASDAQ |
Sep 08, 16:00
5.15
0.00 (0.00%)
Pre-Market: 20:00
SCYNEXIS Debt to Equity Ratio : 0.0291 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0291 |
| March 31, 2026 | 0.0499 |
| December 31, 2025 | 0.044 |
| September 30, 2025 | 0.0627 |
| June 30, 2025 | 0.0537 |
| March 31, 2025 | 0.0492 |
| December 31, 2024 | 0.2954 |
| September 30, 2024 | 0.2716 |
| June 30, 2024 | 0.2573 |
| March 31, 2024 | 0.2056 |
| December 31, 2023 | 0.2067 |
| September 30, 2023 | 0.161 |
| June 30, 2023 | 0.1579 |
| March 31, 2023 | -1.644 |
| December 31, 2022 | 16.82 |
| September 30, 2022 | 2.858 |
| June 30, 2022 | 1.066 |
| March 31, 2022 | 1.231 |
| December 31, 2021 | 1.057 |
| September 30, 2021 | 1.136 |
| June 30, 2021 | 1.352 |
| March 31, 2021 | 0.5978 |
| December 31, 2020 | 0.8719 |
| September 30, 2020 | 1.742 |
| June 30, 2020 | 3.415 |
| Date | Value |
|---|---|
| March 31, 2020 | 2.233 |
| December 31, 2019 | 1.154 |
| September 30, 2019 | 2.602 |
| June 30, 2019 | 1.730 |
| March 31, 2019 | 1.908 |
| December 31, 2018 | 0.483 |
| September 30, 2018 | 0.5368 |
| June 30, 2018 | 0.5598 |
| March 31, 2018 | 0.4007 |
| December 31, 2017 | 0.6844 |
| September 30, 2017 | 0.5337 |
| June 30, 2017 | 0.4565 |
| March 31, 2017 | 0.428 |
| December 31, 2016 | 0.4093 |
| September 30, 2016 | 0.427 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.7344 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 74.97M |
| Total Liabilities (Quarterly) | 8.04M |
| Shareholders Equity (Quarterly) | 66.93M |
| Current Ratio | 9.563 |
| Net Debt Paydown Yield | 0.27% |